Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |